Tradestie Institutional Equity Comparison Engine
CAMP vs SLN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SLN Overall Edge
SLN Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Silence Therapeutics Plc American Depository Share (SLN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus SLN at N/M Forward P/E and -10475.6% operating margin (+197.2% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLN sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CAMP N/M vs SLN N/M Fwd P/E
Growth & Margin Winner
SLN
Op Margin -991.8% vs -10475.6% ยท YoY +138.9% vs +197.2%
Momentum & Technical Winner
SLN
1Y -2.4% vs +190.0% ยท 52W Pos 23% vs 100%
Options & Structure Winner
SLN
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (50th %ile IV)
CAMP
NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap
$238.5M
1M Return
+27.39%
1Y Return
-2.44%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
SLN
NASDAQ
Silence Therapeutics Plc American Depository Share
Pharmaceutical Preparations
$19.80
+0.03% 1D
Market Cap
$1.2B
1M Return
+1.15%
1Y Return
+189.97%
Forward P/E
N/M
Unified AI Score
45.2 / 100
HOLD
Tech 25.0
Fund 34.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CAMP -2.44%
SLN +189.97%
Spread: +192.41 pp (SLN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CAMP TTM Op. Margin: -991.8%
SLN TTM Op. Margin: -10475.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CAMP vs SLN. Trailing 12-month operating profitability (CAMP -991.8% vs SLN -10475.6%) and valuation multiples (CAMP N/M vs SLN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAMP | SLN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.5M | $1.2B | Larger Scale | SLN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +138.9% | +197.2% | Higher Growth | SLN |
| Operating Margin (TTM) Profitability | -991.8% | -10475.6% | Higher Margin | CAMP |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -146.1% | -90.4% | Higher ROE | SLN |
| 52-Week Range Position Momentum | 23% ($3โ$8) | 100% ($4โ$20) | Stronger Trend | SLN |
| Beta / 30D Volatility Risk Regime | 1.35ฮฒ ยท 94% Vol | 1.92ฮฒ ยท 4% Vol | Lower Realized Risk | SLN |
| Unified Institutional Score Composite Signal | 43.9 / 100 (HOLD) | 45.2 / 100 (HOLD) | Higher Composite | SLN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CAMP vs SLN Buy Guide
CAMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SLN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CAMP nor SLN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.